It has been suggested that enhanced angiotensin converting enzyme 2 (ACE2) expression, pre-existing endothelial dysfunction and a procoagulant state induced by adipocytokine deregulation in MS may play a crucial role in the development of severe COVID-19 [16]. The gene discussed is ACE2; the disease is COVID-19.